Your browser doesn't support javascript.
loading
Characteristics and Survival Results of Peritoneal Dialysis Patients Suffering from COVID-19 in Turkey: A Multicenter National Study.
Gursu, Meltem; Ozturk, Savas; Arici, Mustafa; Sahin, Idris; Gokcay Bek, Sibel; Yilmaz, Murvet; Koyuncu, Sumeyra; Karahisar Sirali, Semahat; Ural, Zeynep; Dursun, Belda; Yuksel, Enver; Uzun, Sami; Sipahi, Savas; Ahbap, Elbis; Artan, Ayse Serra; Altunoren, Orcun; Tunca, Onur; Ayar, Yavuz; Gok Oguz, Ebru; Yilmaz, Zulfukar; Kahvecioglu, Serdar; Asicioglu, Ebru; Oruc, Aysegul; Altiparmak, Mehmet Riza; Aydin, Zeki; Huddam, Bulent; Dolarslan, Murside Esra; Azak, Alper; Bakirdogen, Serkan; Yalcin, Ahmet Ugur; Karadag, Serhat; Ulu, Memnune Sena; Gungor, Ozkan; Ari Bakir, Elif; Odabas, Ali Riza; Seyahi, Nurhan; Yildiz, Alaattin; Ates, Kenan.
Afiliação
  • Gursu M; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, BezmialemVakif University, Istanbul, Turkey.
  • Ozturk S; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Arici M; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Istanbul, Turkey.
  • Sahin I; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Malatya Inonu University, Malatya, Turkey.
  • Gokcay Bek S; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
  • Yilmaz M; Division of Nephrology, Department of Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Koyuncu S; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Karahisar Sirali S; Division of Nephrology, Department of Internal Medicine, Ankara Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Ural Z; Division of Nephrology, Department of Internal Medicine, Ankara Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Dursun B; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Pamukkale University, Denizli, Turkey.
  • Yuksel E; Division of Nephrology, Department of Internal Medicine, Diyarbakir Gazi Yasargil Training and Research Hospital, University of Health Sciences, Diyarbakir, Turkey.
  • Uzun S; Division of Nephrology, Department of Internal Medicine, Haseki Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Sipahi S; Division of Nephrology, Department of Internal Medicine, Sakarya University Medical Faculty Education and Research Hospital, Sakarya, Turkey.
  • Ahbap E; Division of Nephrology, Department of Internal Medicine, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Artan AS; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Altunoren O; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
  • Tunca O; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
  • Ayar Y; Division of Nephrology, Department of Internal Medicine, Bursa City Hospital, Bursa Faculty of Medicine, University of Health Sciences, Bursa, Turkey.
  • Gok Oguz E; Division of Nephrology, Department of Internal Medicine, Diskapi Yildirim Beyazit Education and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Yilmaz Z; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Diyarbakir Dicle University, Diyarbakir, Turkey.
  • Kahvecioglu S; Division of Nephrology, Department of Internal Medicine, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa, Turkey.
  • Asicioglu E; Division of Nephrology, Department of Internal Medicine, Pendik Training and Research Hospital, Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Oruc A; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
  • Altiparmak MR; Division of Nephrology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Aydin Z; Division of Nephrology, Department of Internal Medicine, Darica Training and Research Hospital, University of Health Sciences, Kocaeli, Turkey.
  • Huddam B; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey.
  • Dolarslan ME; Division of Nephrology, Department of Internal Medicine, Trabzon Kanuni Training and Research Hospital, University of Health Sciences, Trabzon, Turkey.
  • Azak A; Division of Nephrology, Department of Internal Medicine, Balikesir Atatürk Education and Research Hospital, Balikesir, Turkey.
  • Bakirdogen S; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, Turkey.
  • Yalcin AU; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Karadag S; Division of Nephrology, Department of Internal Medicine, Haseki Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Ulu MS; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Bahçesehir University, Istanbul, Turkey.
  • Gungor O; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
  • Ari Bakir E; Division of Nephrology, Department of Internal Medicine, Dr. Lutfi Kirdar City Hospital, University of Health Sciences, Istanbul, Turkey.
  • Odabas AR; Division of Nephrology, Department of Internal Medicine, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul Medeniyet University, Istanbul, Turkey.
  • Seyahi N; Division of Nephrology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Yildiz A; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Ates K; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara, Turkey.
Kidney Blood Press Res ; 47(10): 605-615, 2022.
Article em En | MEDLINE | ID: mdl-36099904
INTRODUCTION: We aimed to study the characteristics of peritoneal dialysis (PD) patients with coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome. METHODS: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were recorded. RESULTS: We enrolled 142 COVID-19 patients (median age: 52 years). 58.2% of patients had mild disease at diagnosis. Lung involvement was detected in 60.8% of patients. Eighty-three (58.4%) patients were hospitalized, 31 (21.8%) patients were admitted to intensive care unit and 24 needed mechanical ventilation. Fifteen (10.5%) patients were switched to hemodialysis and hemodiafiltration was performed for four (2.8%) patients. Persisting pulmonary symptoms (n = 27), lower respiratory system infection (n = 12), rehospitalization for any reason (n = 24), malnutrition (n = 6), hypervolemia (n = 13), peritonitis (n = 7), ultrafiltration failure (n = 7), and in PD modality change (n = 8) were reported in survivors. Twenty-six patients (18.31%) died in the first month of diagnosis. The non-survivor group was older, comorbidities were more prevalent. Fever, dyspnea, cough, serious-vital disease at presentation, bilateral pulmonary involvement, and pleural effusion were more frequent among non-survivors. Age (OR: 1.102; 95% CI: 1.032-1.117; p: 0.004), moderate-severe clinical disease at presentation (OR: 26.825; 95% CI: 4.578-157.172; p < 0.001), and baseline CRP (OR: 1.008; 95% CI; 1,000-1.016; p: 0.040) were associated with first-month mortality in multivariate analysis. DISCUSSION/CONCLUSIONS: Early mortality rate and medical complications are quite high in PD patients with COVID-19. Age, clinical severity of COVID-19, and baseline CRP level are the independent parameters associated with mortality.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Diálise Peritoneal / COVID-19 Tipo de estudo: Observational_studies Limite: Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Kidney Blood Press Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Diálise Peritoneal / COVID-19 Tipo de estudo: Observational_studies Limite: Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Kidney Blood Press Res Ano de publicação: 2022 Tipo de documento: Article